JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M502065200 on March 18, 2005

J. Biol. Chem., Vol. 280, Issue 21, 20516-20523, May 27, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
280/21/20516    most recent
M502065200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van den Born, J.
Right arrow Articles by Salmivirta, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van den Born, J.
Right arrow Articles by Salmivirta, M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Novel Heparan Sulfate Structures Revealed by Monoclonal Antibodies*

Jacob van den Born{ddagger}, Katriina Salmivirta§, Tiina Henttinen||, Nina Östman||, Takeshi Ishimaru**, Shuichi Miyaura**, Keiichi Yoshida**, and Markku Salmivirta||{ddagger}{ddagger}

From the {ddagger}Department of Molecular Cell Biology and Immunology, Vrije Universiteit Medical Center, Amsterdam 1007 MB, The Netherlands, the §Department of Animal Physiology, Uppsala University, Uppsala SE-75123, Sweden, the MediCity Research Laboratory, University of Turku and National Public Health Institute, Turku FIN-20520, Finland, the ||Turku Centre for Biotechnology, University of Turku and Åbo Akademi University, Turku FIN-20520, Finland, and the **Seikagaku Corporation, Central Research Laboratories, Tokyo 207-0021, Japan

The sulfated glycosaminoglycan heparan sulfate (HS) is found ubiquitously on cell surfaces, in the extracellular matrix, and intracellularly as HS proteoglycans. Because of the structural heterogeneity of HS, tissue-derived HS preparations represent a mixture of HS chains originating from different cell types and tissue loci. Monoclonal anti-HS antibodies have been employed to detect the localization of specific HS epitopes in tissues, but limited information has been available on the saccharide structures recognized by the antibodies. We have studied the saccharide epitope structures of four anti-HS antibodies, HepSS1, JM13, JM403, and 10E4, which all recognize distinct HS species as demonstrated by different patterns of immunoreactivity upon staining of embryonic rat and adult human tissues. The epitopes recognized by JM13 and HepSS1 were found almost exclusively in basement membrane HS, whereas JM403 and 10E4 reacted also with cell-associated HS species. The binding of HepSS1, JM403, and 10E4 to HS was dependent on the GlcN N-substitution of the polysaccharide rather than O-sulfation. HepSS1 thus interacted with N-sulfated HS domains, JM403 binding was critically dependent on N-unsubstituted GlcN residues, and 10E4 bound to "mixed" HS domains containing both N-acetylated and N-sulfated disaccharide units. By contrast, JM13 binding seemed to require the presence of 2-O-sulfated glucuronic acid residues.


Received for publication, February 23, 2005

* This work was supported by the Academy of Finland Grants 78400 and 20688, the Sigrid Jusélius Foundation, Finnish cancer organizations, K. Albin Johanssons Stiftelse, Polysackaridforskning AB, and the Mizutani Foundation for Glycoscience. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

{ddagger}{ddagger} To whom correspondence should be addressed: Turku Centre for Biotechnology, University of Turku and Åbo Akademi University, Tykistökatu 6, FIN-20520 Turku, Finland. Tel.: 358-2-333-8649; Fax: 358-2-333-8000; E-mail: markku.salmivirta{at}btk.fi.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DevelopmentHome page
Y. Pan, C. Carbe, A. Powers, E. E. Zhang, J. D. Esko, K. Grobe, G.-S. Feng, and X. Zhang
Bud specific N-sulfation of heparan sulfate regulates Shp2-dependent FGF signaling during lacrimal gland induction
Development, January 15, 2008; 135(2): 301 - 310.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
J. W. A. M. Celie, R. M. Reijmers, E. M. Slot, R. H. J. Beelen, M. Spaargaren, P. M. ter Wee, S. Florquin, and J. van den Born
Tubulointerstitial heparan sulfate proteoglycan changes in human renal diseases correlate with leukocyte influx and proteinuria
Am J Physiol Renal Physiol, January 1, 2008; 294(1): F253 - F263.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Vanpouille, A. Deligny, M. Delehedde, A. Denys, A. Melchior, X. Lienard, M. Lyon, J. Mazurier, D. G. Fernig, and F. Allain
The Heparin/Heparan Sulfate Sequence That Interacts with Cyclophilin B Contains a 3-O-Sulfated N-Unsubstituted Glucosamine Residue
J. Biol. Chem., August 17, 2007; 282(33): 24416 - 24429.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
T. A.H. Jarvinen and E. Ruoslahti
Molecular Changes in the Vasculature of Injured Tissues
Am. J. Pathol., August 1, 2007; 171(2): 702 - 711.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
A. Abramsson, S. Kurup, M. Busse, S. Yamada, P. Lindblom, E. Schallmeiner, D. Stenzel, D. Sauvaget, J. Ledin, M. Ringvall, et al.
Defective N-sulfation of heparan sulfate proteoglycans limits PDGF-BB binding and pericyte recruitment in vascular development
Genes & Dev., February 1, 2007; 21(3): 316 - 331.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
Y. Pan, A. Woodbury, J. D. Esko, K. Grobe, and X. Zhang
Heparan sulfate biosynthetic gene Ndst1 is required for FGF signaling in early lens development
Development, December 15, 2006; 133(24): 4933 - 4944.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. van den Born, B. Pisa, M. A. H. Bakker, J. W. A. M. Celie, C. Straatman, S. Thomas, G. C. Viberti, L. Kjellen, and J. H. M. Berden
No Change in Glomerular Heparan Sulfate Structure in Early Human and Experimental Diabetic Nephropathy
J. Biol. Chem., October 6, 2006; 281(40): 29606 - 29613.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. B. t. Dam, S. Kurup, E. M. A. van de Westerlo, E. M. M. Versteeg, U. Lindahl, D. Spillmann, and T. H. van Kuppevelt
3-O-Sulfated Oligosaccharide Structures Are Recognized by Anti-heparan Sulfate Antibody HS4C3
J. Biol. Chem., February 24, 2006; 281(8): 4654 - 4662.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. H. D. Bassett, R. Swinhoe, O. Chassande, J. Samarut, and G. R. Williams
Thyroid Hormone Regulates Heparan Sulfate Proteoglycan Expression in the Growth Plate
Endocrinology, January 1, 2006; 147(1): 295 - 305.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.